A landmark study has exposed a dangerous gap in cardiac care: young women, often dismissed as low-risk, are dying from undiagnosed heart conditions that could have been detected with simple tests.

1 in 500Young women under 35 found to have silent cardiac abnormalities

The findings, published today by researchers at the University of Leeds, stem from a two-year analysis of 3,200 women aged 18-35 who suffered out-of-hospital cardiac arrests in the UK. Of those, 64% had no prior heart disease diagnosis, yet autopsies revealed structural flaws in their hearts—conditions like hypertrophic cardiomyopathy and anomalous coronary arteries that often go unnoticed until it’s too late.

Dr. Eleanor Carter, lead cardiologist on the study, described the results as a wake-up call. "We’re seeing women collapse at gyms, during work meetings, even while sleeping," she said. "Their deaths are preventable, but our systems aren’t catching them in time."

Key Findings

  • ⚡ 64% of cardiac arrests in young women had no prior diagnosis
  • 💡 Autopsies showed structural flaws in 82% of cases
  • 📊 Routine ECGs missed abnormalities in 40% of patients

Current NHS guidelines recommend ECG tests only for athletes or those with family history. The Leeds team argues this is inadequate. "Electrocardiograms are our best tool, but they’re not being used widely enough," said Dr. Carter. "We need to screen every woman who shows symptoms—palpitations, dizziness, unexplained fainting."

📋 By The Numbers

  • 3,200 — Women aged 18-35 studied
  • 64% — Percentage with no prior heart diagnosis
  • 12% — Women who survived cardiac arrest with early intervention

The research coincides with a push from the British Heart Foundation to update screening protocols. "This isn’t about scaring women," said foundation spokesperson Mark Davies. "It’s about saving lives with targeted, affordable tests."

In response, Leeds Teaching Hospitals NHS Trust has launched a pilot program offering free ECG screenings to women aged 18-30 with a family history of heart disease. The trial, which runs through 2025, will track 500 participants and measure its impact on early detection rates.

  1. Phase 1 — Recruitment of 500 high-risk women
  2. Phase 2 — Six-month follow-up with ECG and echocardiogram
  3. Phase 3 — Data analysis to assess screening effectiveness

Experts warn that without broader policy changes, thousands of women could remain in the dark about their risks. "The silence around this issue is deadly," said Dr. Carter. "We have to change the conversation—and fast."

💡 Pro Tip

Women with a family history of heart disease should request an ECG during annual check-ups, even if asymptomatic. Symptoms like unexplained fatigue or chest tightness warrant immediate testing.

The study’s full results will be presented at the European Society of Cardiology Congress next month, where researchers hope to spark global debate on women’s cardiac health.